Supreme Court seems skeptical of effort to limit access to abortion pill
A majority of the Supreme Court seemed less than favorable toward a bid to sharply limit access to mifepristone, a key medication in more than 60 percent of U.S. abortions. As they weighed the FDA v. Alliance for Hippocratic Medicine case, the justices questioned whether anti-abortion doctors have sufficient legal grounds — or standing — to bring the lawsuit. Plus, Donald Trump's media company, Truth Social, soars on its first day of trading on Nasdaq. And the impact of Baltimore's Key Bridge collapse after a cargo ship collision. Josh Gerstein, Tara Palmeri, Dr. Kavita Patel, Ron Insana, Bill Cohan, Reed Galen, Ron Filipkowski, and George Solis join.